Do You Need a License to Sell Peptides in Indiana?

There is no single, standalone "peptide license" to apply for in Indiana. What you need depends on which business you are actually operating: every commercial seller needs a properly registered business entity and the ordinary state and local registrations that go with it, while separate regulatory regimes may attach if what you are selling falls into a drug, compounded-preparation, or wholesale-distribution category. Research-use-only material sold business-to-business sits in a different lane again, and that lane has its own boundaries. This article explains the framework and the questions to ask; it is informational and is not legal advice. The binding answer for your model comes from an Indiana-licensed attorney and, where relevant, the applicable state board or agency.

Three different questions hiding inside one

Most operators asking about licensing are actually asking three questions at once, and they have three different answers.

The first is commercial: am I allowed to run a business and sell things? That is entity formation, tax registration, and whatever local requirements apply where you operate. It is the floor, and it applies to a reseller shipping boxes exactly as it applies to a retailer.

The second is regulatory: does the specific thing I am selling fall into a category that carries its own licensure? This is where peptides get complicated, because "peptide" is a chemistry word, not a legal category. A short amino acid chain can sit in very different regulatory buckets depending on how it is manufactured, how it is labeled, what claims travel with it, and who the end buyer is. The answer for one compound is not automatically the answer for another.

The third is professional: does someone in my business hold a license that governs their own conduct? A clinician, pharmacist, or licensed practitioner carries obligations from their board that exist independently of anything the business entity does. Those obligations do not disappear because a company was formed around them.

Confusing the three is the most common way an otherwise careful operator ends up with a plan their counsel has to unwind. Answer them separately.

The registrations every seller shares

Before anything category-specific, there is the baseline that applies to any business selling goods. You need a legal entity in good standing, registration with the state for tax purposes where sales are taxable, and any local permitting that attaches to your address or activity type. If you are shipping physical inventory, you also inherit the ordinary obligations of a goods business: recordkeeping, invoicing, and the ability to show where product came from.

None of that is peptide-specific, and none of it is optional. It is also the part most suppliers will check first, because a supplier that cannot verify you are a real, registered business has no basis for opening a wholesale account at all.

What this baseline does not do is answer the second question. Registering an entity gives you the right to do business; it does not decide which categories of product you may hold, label, and move. Treating a business registration as blanket authorization for anything you decide to stock is the single most expensive assumption in this market.

Where an ordinary sale becomes a regulated one

The regulated-distribution question turns on category, and category turns on facts you control. Manufacturing, repackaging, relabeling, or holding certain classes of product for onward sale can pull a business into licensure schemes that ordinary retailers never encounter. Adding claims (about what a compound does for a person, what condition it addresses, or what outcome a buyer should expect) can change how the product is characterized regardless of what the label says elsewhere. So can the intended end use you advertise or knowingly facilitate.

That is worth sitting with, because it means the same vial can be a different regulatory object in two different businesses. Nothing about the molecule changed. What changed was the framing, the claims, and the customer.

This is exactly why blanket internet answers fail. Someone saying "peptides are unregulated" and someone saying "you need a distributor license" may both be describing something real about their own facts and neither may be describing yours. The durable rule is that the category determines the licensure, you determine the category by how you operate, and only an attorney reviewing your actual model can tell you which side of the line you are on.

What research-use-only framing does, and does not, do

Research-use-only is a real and meaningful designation. It means the material is supplied for laboratory and research applications, is not an approved drug, and is not supplied for human consumption. Real Peptides sells on exactly that basis: every compound in the catalog is research use only, sold business-to-business, and never characterized as a therapeutic.

What that framing does is define the transaction honestly. It tells a buyer what they are purchasing and what they are not purchasing. It keeps the supplier's representations aligned with reality, and it gives your compliance counsel a clean starting point rather than a mess to reconstruct.

What it does not do is function as a shield you can bolt onto any downstream activity. If a business takes research-use-only material and markets it, positions it, or moves it in a way inconsistent with that designation, the label on the vial is not the fact that governs. Regulators and courts generally look at conduct and intent, not just packaging. Research suggests a great deal about how various peptides behave in laboratory models, and that science is genuinely interesting, but interesting science is not a permission slip, and no supplier can convert one into the other on your behalf.

So the honest version is this: research-use-only sourcing is necessary for a compliant research-supply business and it is not sufficient by itself. It is the beginning of your compliance posture, not the whole of it.

The questions to put in front of counsel

Go into the conversation with your attorney knowing what to ask. Vague questions get vague answers and burn billable time. These are the ones that actually move a decision.

Bring that list to an Indiana-licensed attorney rather than to a forum. Confirm current requirements with the state board or agency that would actually have jurisdiction over your activity, because agency positions and state rules change and nothing in an article is a substitute for checking them directly.

How a serious supplier qualifies a buyer

Here is a signal worth reading. A supplier that opens a wholesale account for anyone with a credit card is telling you something about how much scrutiny it expects, and about how much it will withstand.

Good suppliers ask questions. They want to know what business you operate, how you are registered, and how you intend to position what you buy. That friction is not gatekeeping for its own sake; it is a supplier taking its own compliance seriously, which is the same trait you will depend on when a customer, a processor, or your own counsel asks where your material came from.

Apply the same scrutiny in reverse. Ask whether pricing is transparent or only revealed after a sales call. Ask whether certificates of analysis are published for anyone to inspect, or sold as an add-on, or produced on request in a form you cannot trace back to a batch. Ask what panels the testing actually covers, because "tested" without a named method and a named panel is a word, not a fact. Ask where fulfillment happens. Plenty of operations in this market are structurally unable to answer those questions, and that inability is the answer.

What Real Peptides does differently

Real Peptides builds its Wholesale Partner Program around documentation the buyer can verify without taking anyone's word for it.

Every compound is tested to 99%+ HPLC purity and runs through 7-panel batch testing. The certificates of analysis are publicly verifiable: you can check the lab results yourself, before you open an account, without asking a salesperson to email you something. That matters because a COA you cannot independently inspect is a marketing asset, not a quality control. Fulfillment is handled in the US with 5-7 day delivery, so your inventory planning does not depend on an opaque overseas pipeline.

Wholesale access runs through a 3-step application. It exists so that accounts are opened with businesses that have thought through their model, and so that both sides know what the relationship is: business-to-business supply of research-use-only compounds, documented, with no claims attached that the science does not support. Everything is supplied for research applications only and is never sold for human consumption or described as a therapeutic.

If your legal groundwork is done and you want a supply relationship where the testing, the pricing, and the paperwork are all visible up front, the Wholesale Partner Program application is the next step: bring your entity details and a clear description of the business you are running, and expect the questions.

For more on how wholesale pricing and account structure work, see the wholesale peptides program, read the broader overview of do you need a license to sell peptides, or apply for a wholesale account when your paperwork is in order.